MiMARK Diagnostics SL

Description

MiMARK Diagnostics SL develops protein-based diagnostic assays that analyze minimally invasive gynecological fluid samples and translate mass-spectrometry biomarker candidates into validated immunoassays for clinical laboratory use.

MiMARK Diagnostics SL is located in the Barcelona ecosystem.

Related

• UniogenUniogen provides biotech CDMO services, develops custom assays and laboratory instruments, and creates technologies—such as glycovariant…
• CroíValveCroíValve develops the DUO Adapt™ System, a minimally invasive transcatheter heart valve device for treating tricuspid regurgitation in…
• Neurent MedicalNeurent Medical develops the NEUROMARK System, a radiofrequency-based ENT medical device that targets posterior nasal nerves to provide…
• Cyted HealthCyted Health combines minimally invasive cell collection with molecular analysis to build diagnostic tests (EndoSign®) for earlier…
• Sequentia BiotechSequentia Biotech provides bioinformatics solutions, custom software, and expert consulting that analyze multiomics and NGS data for…
• cellavisioncellavision provides digital hematology microscopy solutions that automate cell morphology workflows through analyzers, instruments,…
• Owlstone MedicalOwlstone Medical develops Breath Biopsy products and services that analyse volatile organic compounds (VOCs) from breath and other samples…
• SympheraSymphera develops an integrated surgical system that combines multiple instruments into one device, enabling intra-body tool switching to…
• Rab DiagnosticsRab Diagnostics develops biomarker tools, assays and the RabCANCER platform to predict antibody–drug conjugate response for pharma…